10:00 - 10:05

Marius Trøseid and Johannes Hov
Welcome

10:05 - 10:20

Andraz Nendl
Intestinal fatty acid binding protein is associated with cardiac dysfunction and gut microbiota alterations in chronic heart failure

10:20 - 10:35

Jonas Lundekvam
Proof of concept study; Probiotic intervention in patients with Ulcerative Colitis with insufficient response to anti-TNF treatment

10:35 - 10:50

Line Gaundal
Replacing saturated fatty acids with polyunsaturated fatty acids increases the abundance of Lachnospiraceae and is associated with reduced total cholesterol levels - a randomized controlled trial in healthy individuals

10:50 - 11:20

Keynote Lecturer Peter Holger Johnsen
Update on fecal microbiota transplantation: Where are we - where are we moving

11:20 - 11:45

Break

11:45 - 12:00

Petra Hradicka
Human faecal microbiota transplant in mice (hFMT): how to increase the efficacy to resemble human microbiota composition?

12:00 - 12:15

Ida Rud
Ratio-dependent effect of arabinoxylan and beta-glucan on microbiota and SCFAs during in vitro fermentation

12:15 - 12:30

Polona Rajar
Microbial DNA extraction of high-host content and low biomass samples: optimized protocol for nasopharynx metagenomic studies

12:30 - 12:45

Warren Flood
Development of a high-throughput qPCR platform for precise taxonomic characterization of the human gut microbiome

12:45 - 13:00

Silje Jørgensen
Duodenal inflammation in Common variable immunodeficiency has altered transcriptional response to viruses

13:00 - 14:00

Lunch

14:00 - 14:45

Keynote Lecturer Fredrik Bäckhed
Human Microbiome as a regulator of host physiology and metabolism

14:45 - 15:00

Break

15:00 - 15:15

Ekaterina Avershina
Total neoplastic polyp volume is correlated to several bacterial taxa in faecal immunochemical test-positive CRC-screening patients

15:15 - 15:30

Paula Istvan
Diverse virome in fecal immunochemical tests from bowel cancer screening participants

15:30 - 15:45

Christine Olbjørn
Targeted microbiota profiling, for diagnosis, prognosis and treatment individualization in pediatric inflammatory bowel disease

15:45 - 16:00

Marius Trøseid and Johannes Hov
Closing remarks